Danaher Co. (NYSE:DHR) Stock Position Decreased by DB Fitzpatrick & Co Inc

DB Fitzpatrick & Co Inc lowered its holdings in Danaher Co. (NYSE:DHR) by 2.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,147 shares of the conglomerate’s stock after selling 172 shares during the period. Danaher comprises about 1.7% of DB Fitzpatrick & Co Inc’s investment portfolio, making the stock its 12th biggest holding. DB Fitzpatrick & Co Inc’s holdings in Danaher were worth $1,870,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Dakota Community Bank & Trust NA lifted its stake in Danaher by 16.4% in the fourth quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock valued at $73,000 after buying an additional 45 shares during the last quarter. Folger Nolan Fleming Douglas Capital Management Inc. grew its position in Danaher by 3.1% in the 4th quarter. Folger Nolan Fleming Douglas Capital Management Inc. now owns 4,037 shares of the conglomerate’s stock worth $927,000 after purchasing an additional 120 shares during the last quarter. Brooklyn Investment Group increased its stake in shares of Danaher by 7.7% in the fourth quarter. Brooklyn Investment Group now owns 5,289 shares of the conglomerate’s stock valued at $1,214,000 after purchasing an additional 378 shares during the period. Sax Wealth Advisors LLC boosted its position in shares of Danaher by 83.7% during the fourth quarter. Sax Wealth Advisors LLC now owns 3,260 shares of the conglomerate’s stock worth $748,000 after buying an additional 1,485 shares during the period. Finally, Merit Financial Group LLC grew its holdings in Danaher by 14.3% in the 4th quarter. Merit Financial Group LLC now owns 10,050 shares of the conglomerate’s stock worth $2,307,000 after buying an additional 1,260 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 1.4 %

NYSE:DHR opened at $238.41 on Friday. Danaher Co. has a 1-year low of $222.53 and a 1-year high of $281.70. The firm has a market capitalization of $172.20 billion, a price-to-earnings ratio of 45.50, a PEG ratio of 4.23 and a beta of 0.83. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The business’s fifty day moving average price is $234.99 and its 200 day moving average price is $253.37.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company posted $2.02 earnings per share. On average, sell-side analysts forecast that Danaher Co. will post 7.49 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s dividend payout ratio is 20.61%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Stephens reissued an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Stifel Nicolaus upped their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Guggenheim assumed coverage on Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Evercore ISI lifted their price target on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Finally, KeyCorp upped their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $286.80.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.